Financial Statements

Meridian Bioscience, Inc. (VIVO)

$31.96

-0.05 (-0.16%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) 109635047-
Net Income 7146242422
Stock Dividends ---0-50
Dividend Paid ---11-21-24
Retained Earnings 181109635047

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 37313031-
Annual Depreciation 30104435
Capital Expenditure -18-3-4-4-4
Net PPE 4937313031

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -555589114
New Purchases -----
Intangible and Goodwill 555589114115

Meridian Bioscience, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Meridian Bioscience, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.